Effects of Extracted Pulse Proteins on Lipid Targets for Cardiovascular Risk Reduction: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Nutrients. 2024 Nov 1;16(21):3765. doi: 10.3390/nu16213765.

Abstract

Background: Many clinical practice guidelines recommend dietary pulses for the prevention and management of cardiovascular disease and diabetes. The impact of extracted pulse proteins remains unclear. We therefore conducted a systematic review and meta-analysis of randomized controlled trials of the effect of extracted pulse proteins on therapeutic lipid targets.

Methods and findings: MEDLINE, Embase, and the Cochrane Library were searched through April 2024 for trials of ≥3-weeks. The primary outcome was low-density lipoprotein-cholesterol (LDL-C). The secondary outcomes were other lipid targets. Independent reviewers extracted data and assessed the risk of bias. Subgroup analyses included by pulse type and the certainty of evidence was assessed using GRADE.

Results: Seven included trials (14 trial comparisons, n = 453) with a median of 4-weeks duration and dose of 35 g/day showed that extracted pulse proteins decreased LDL-C by -0.23 mmol/L (95% confidence interval: -0.36 to -0.10 mmol/L, p < 0.001). Similar effects were observed for non-high-density lipoprotein-cholesterol and apolipoprotein B. No interactions were found by pulse type. Subgroup analyses revealed effect modification by sex, with greater proportions of females seeing greater reductions. GRADE was generally moderate.

Conclusions: Extracted pulse proteins likely result in moderate reductions in LDL-C and other lipid targets. Future studies on various types of extracted pulse proteins including assessments by sex are warranted.

Keywords: blood lipids; cardiovascular; dietary pulses; extracted proteins; meta-analysis; sex; systematic review.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Cardiovascular Diseases* / prevention & control
  • Cholesterol, LDL* / blood
  • Female
  • Heart Disease Risk Factors
  • Humans
  • Lipids / blood
  • Male
  • Randomized Controlled Trials as Topic
  • Risk Reduction Behavior

Substances

  • Cholesterol, LDL
  • Lipids

Grants and funding

S.Y. received research support from a Banting and Best Diabetes Centre Charles Hollenberg Summer Studentship. S.B. received research support from an internal sabbatical research grant awarded to SMG through Mount Saint Vincent University 2022–23, an Undergraduate Research Opportunity Program Award from the Department of Nutritional Sciences, University of Toronto, and a Toronto 3D Knowledge Synthesis Summer Student Top-Up Award. S.A.-C. received research support from a CIHR Canadian Graduate Scholarship Doctoral Award (funding reference number 476251). S.M.G. received support through an internal sabbatical research grant, awarded to SMG through Mount Saint Vincent University, 2022–23, and an internal travel grant, awarded to SMG through Mount Saint Vincent University, 2022. V.C. was funded by a Toronto 3D Research Fellowship Award, CIHR Canada Graduate Scholarship—Masters (CGS-M) Research Award, and a University of Toronto Department of Nutritional Sciences Fellowship. A.Z. was funded by the Toronto 3D Postdoctoral Fellowship Award. Y.-T.C. received research support from the Toronto 3D Knowledge Synthesis Summer Student Scholarship. E.J.L. received research support from an Undergraduate Research Opportunity Program Award from the Department of Nutritional Sciences, University of Toronto. D.J.A.J. was funded by the Government of Canada through the Canada Research Chair Endowment. L.C. was funded by a Toronto 3D New Investigator Award.